NCT05756322
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05756322
Title The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Lin BioScience, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Moffitt Cancer Center NOT_YET_RECRUITING Tampa Florida 33612 United States Details
Robert H. Lurie Comprehensive Cancer Center of Northwestern University NOT_YET_RECRUITING Chicago Illinois 60611 United States Details
The University of Kansas Hospital RECRUITING Fairway Kansas 66205 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins NOT_YET_RECRUITING Baltimore Maryland 21287 United States Details
UNC Hospitals, The University of North Carolina at Chapel Hill RECRUITING Chapel Hill North Carolina 27599 United States Details
Wollongong Private Hospital ACTIVE_NOT_RECRUITING Wollongong New South Wales Australia Details
Pindara Private Hospital ACTIVE_NOT_RECRUITING Benowa Queensland Australia Details
The Royal Adelaide Hospital RECRUITING Adelaide South Australia Australia Details
The Alfred Hospital RECRUITING Melbourne Victoria Australia Details
Hollywood Private Hospital ACTIVE_NOT_RECRUITING Nedlands Washington Australia Details
Q Medical Conselling NOT_YET_RECRUITING Perth Western Australia 6009 Australia Details
China Medical University Hospital NOT_YET_RECRUITING Taichung Taiwan Details
National Cheng Kung University Hospital NOT_YET_RECRUITING Tainan Taiwan Details
National Taiwan University Hospital NOT_YET_RECRUITING Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field